ArticleAmerican journal of hematology2018

Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect.

Armin Rashidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.